630 related articles for article (PubMed ID: 32593798)
1. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Parker C; Castro E; Fizazi K; Heidenreich A; Ost P; Procopio G; Tombal B; Gillessen S;
Ann Oncol; 2020 Sep; 31(9):1119-1134. PubMed ID: 32593798
[No Abstract] [Full Text] [Related]
2. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Horwich A; Parker C; de Reijke T; Kataja V;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi106-14. PubMed ID: 23813930
[No Abstract] [Full Text] [Related]
3. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Horwich A; Parker C; Bangma C; Kataja V;
Ann Oncol; 2010 May; 21 Suppl 5():v129-33. PubMed ID: 20555062
[No Abstract] [Full Text] [Related]
4. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer.
Kataja VV;
Ann Oncol; 2003 Jul; 14(7):1010-1. PubMed ID: 12853339
[No Abstract] [Full Text] [Related]
5. Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Horwich A; Parker C; Kataja V;
Ann Oncol; 2008 May; 19 Suppl 2():ii45-6. PubMed ID: 18456765
[No Abstract] [Full Text] [Related]
6. What your patient needs to know about prostate cancer.
Held-Warmkessel J
Nursing; 2002 Dec; 32(12):36-42; quiz N232. PubMed ID: 12468938
[No Abstract] [Full Text] [Related]
7. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.
Kanesvaran R; Castro E; Wong A; Fizazi K; Chua MLK; Zhu Y; Malhotra H; Miura Y; Lee JL; Chong FLT; Pu YS; Yen CC; Saad M; Lee HJ; Kitamura H; Prabhash K; Zou Q; Curigliano G; Poon E; Choo SP; Peters S; Lim E; Yoshino T; Pentheroudakis G
ESMO Open; 2022 Aug; 7(4):100518. PubMed ID: 35797737
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Parker C; Gillessen S; Heidenreich A; Horwich A;
Ann Oncol; 2015 Sep; 26 Suppl 5():v69-77. PubMed ID: 26205393
[No Abstract] [Full Text] [Related]
9. Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
Kamidono S; Ohshima S; Hirao Y; Suzuki K; Arai Y; Fujimoto H; Egawa S; Akaza H; Hara I; Hinotsu S; Kakehi Y; Hasegawa T;
Int J Urol; 2008 Jan; 15(1):1-18. PubMed ID: 18184166
[No Abstract] [Full Text] [Related]
10. Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Horwich A; Parker C; Kataja V;
Ann Oncol; 2009 May; 20 Suppl 4():76-8. PubMed ID: 19454471
[No Abstract] [Full Text] [Related]
11. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
[TBL] [Abstract][Full Text] [Related]
12. Facing up to prostate cancer.
Ficorelli CT; Weeks B
Nursing; 2006 May; 36(5):66-8. PubMed ID: 16670611
[No Abstract] [Full Text] [Related]
13. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
Miki T
Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
[No Abstract] [Full Text] [Related]
14. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.
Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
Urology; 1995 Sep; 46(3):277-89. PubMed ID: 7544931
[No Abstract] [Full Text] [Related]
15. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer.
Schlegel PN
Curr Ther Endocrinol Metab; 1994; 5():543-50. PubMed ID: 7535663
[No Abstract] [Full Text] [Related]
17. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
[TBL] [Abstract][Full Text] [Related]
18. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
Kantoff PW; Talcott JA
Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
[TBL] [Abstract][Full Text] [Related]
19. Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?
Klotz L
Curr Urol Rep; 2007 Sep; 8(5):341-4. PubMed ID: 17880830
[No Abstract] [Full Text] [Related]
20. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
